Immediate Impact
50 standout
Citing Papers
Pharmacogenomics: current status and future perspectives
2023 Standout
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19
2022 Standout
Works of R Welte being referenced
Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries: Applying a Standardized Costing Methodology
2012
Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| R Welte | 366 | 381 | 369 | 45 | 1.1k | |
| David Meyers | 116 | 308 | 805 | 42 | 1.4k | |
| Noelle M. Cocoros | 122 | 465 | 152 | 74 | 1.1k | |
| Heather Hsu | 263 | 580 | 254 | 46 | 1.4k | |
| A. Bouckaert | 128 | 432 | 152 | 57 | 1.4k | |
| Mary Linehan | 110 | 412 | 113 | 53 | 1.1k | |
| Kate K. Orroth | 256 | 449 | 302 | 30 | 1.0k | |
| Iman Ridda | 158 | 687 | 76 | 36 | 1.4k | |
| A R Hinman | 74 | 498 | 363 | 29 | 1.3k | |
| Charles Stoecker | 175 | 822 | 185 | 65 | 1.4k | |
| Phoebe Thorpe | 279 | 211 | 156 | 29 | 1.3k |
All Works
Loading papers...